Dinar Kale

Senior Lecturer in International Development and Innovation


I hold an MSc in Organic Chemistry (University of Pune), an MBA in Marketing Management (University of Pune) and a PhD (The Open University Business School). My work concerns investigating issues that help or hinder innovation and development of the healthcare industries from developing countries. Before starting my PhD studies I worked in India with a biotechnology company and a highly respected medical device company managing operations in Western India region. After completion of my PhD I joined DPP on an ESRC funded project ‘Issues involved in diffusion of knowledge through migration of scientific labour in India’ and then school of Management at the University of Surrey. I am currently working as Senior Lecturer in International development and innovation at the Development Policy and Practice group. I am also associated with the Innogen Institute and School of Social and Political Science at the University of Edinburgh.

My current work involves understanding role regulation and intermediaries such as industry associations play in facilitating inclusive innovation in emerging and low income countries. This research concentrates on healthcare sector and covers institutional and firm level issues in the medical device and biotechnology industries in India and South Africa.  The broader aim is to understand implication of inclusive innovations in ensuring affordable and accessible healthcare for poor people in developing countries.

My previous work involved significant research on industrial dynamics in industries from developing countries specifically focusing on evolution of capabilities, technology strategies and firm level issues involved in innovation management. It included investigating various issues associated with technology strategy, industrial development and inclusive innovation in developing countries.

I am currently involved in teaching postgraduate modules on Global Development Management. It includes managing intrdouctory module:  T877 Development: Context and Practice and contributing to T878 Capacities for Managing Development

Emergence of biosimilar market and emerging country suppliers

In healthcare sector around the world a new market for biosimlars - copycat products produced at lower prices is emerging and which can potentially severely affect the business models of existing firms in the new era. The rise in demand for biosimilars and capabilities for cheap production in developing countries has potential to disrupt current market structure and transform patient care in bo...

Innovations for Pro-Poor Growth

A burgeoning area of interest for DPP members is the issue of how innovative activity can promote and support entrepreneurship in order to raise the income, welfare and agency of the poorest in society.  Initial ideas for the project and its conceptual base are available at www.ipg.open.ac.uk. This project currently supports three PhD students who are l...

Internationalisation of Indian pharmaceutical industry

In last decade leading Indian pharmaceutical firms has invested in acquisition of firms from overseas advance countries such as USA and Europe.These new Indian MNEs are dominating global pharmaceutical markets and challenging existing paradigms of international business literature. In this context this project tries to explore whether internationalisation of firms from developing countries can...

Issues involved in diffusion of knowledge through migration of scientific labour in India

In the past, ‘brain drain’ has proved to be a big curse for developing countries like India and China but in the emerging global competitive environment, the brain drain can provide crucial advantage to these formerly backward regions. Through successful diffusion of knowledge the communities of such scientists and engineers can provide the skill and know-how needed to help local firms shif...

Medical devices mismatch in Southern countries

Medical devices forms key part of comprehensive healthcare all over the world. However there are key concerns regarding availability and affordibility of medical devices in the developing world. Most of the medical devices are developed and manufactured by firms based in advanced countries targetting customers in similar markets. It creates a mismatch between avalibility and needs of people in ...

The evolution of global manufacturing prices from 1988-2006

This paper analyses the pattern of price changes between 1989 and 2006 of imports into the EU, Japan and the US and compares the price change of exports from China with the price changes of exports from other countries grouped by income level, distinguishing among goods of different technological intensity.

Main Objectives:

By analysing the evolution of the prices...

Unpacking the role of industry associations

This project tries to get inside the black box of innovation and politics, researching whether and in what ways biopharmaceutical associations in developing countries promote technological capabilities and effective governance of health innovation. The overarching aim is to produce a theoretically embedded, empirically-grounded, and policy relevant analysis of the role of biopharmaceutical asso...

Business World: Fix The Missing Link

Dinar Kale analyses the medical device industry and it neglect by policy-makers and industry associations for Business World.

The medical device industry forms an important pillar of healthcare supply industries. It plays a central role in patient care, starting with diagnosis, treatment, in the OT, at the bed side, post-surgery and, in some cases, even after discharge. The medical devic...

Cross roads for pharma in India

Dr. Dinar Kale discusses future of Indian pharmaceutical industry

http://www.pharmaphorum.com/2011/02/21/cross-roads-for-pharma-in-india/

Getting to Know: Mathematics, Computing & Technology (MCT) Faculty

As part of the OU's Getting to Know podcast series, members of MCT, including IKD's Julius Mugwagwa and Dinar Kale, provide a short introduction to their research and teaching. Both Julius and Dinar's work centres on the provision of affordable and appropriate healthcare in developing countries. 

To watch: www.innogen.ac.uk

The changing role of key stakeholders in pharmaceutical value chain

Dr Dinar Kale on changing role of key stakeholders in pharmaceutical value chain

http://www.pharmaphorum.com/2011/11/30/the-changing-role-of-key-stakeholders-in-pharmaceutical-value-chain/

Dr Dinar Kale

Development Policy and Practice
Faculty of Arts and Social Sciences
The Open University
Walton Hall
Milton Keynes
MK7 6AA

Tel: + 44 (0) 1908 652 884
Fax: + 44 (0) 1908 654 825
Email: Dinar Kale